Al-Ola A Abdallah and Nausheen Ahmed
Aug 4, 2025, 12:30
Al-Ola A Abdallah: Nausheen Ahmed on CAR T-cell therapy at the ICE-T 2025
Al-Ola A Abdallah, Director of Plasma Cell Disorder Program at the University of Kansas Medical Center, shared a post on X:
“Highlight from ICE-T2025
CancerNetwork spoke with Dr. Nausheen Ahmed at the inaugural National Immune Cell Effector Therapy (ICE-T) Conference.
Focus: Making CAR T-cell therapy safer and more accessible for patients nationwide. See Full article.”
More posts featuring Al-Ola A Abdallah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2025, 21:28
Sep 6, 2025, 20:34
Sep 6, 2025, 20:20
Sep 6, 2025, 20:00
Sep 6, 2025, 19:13
Sep 6, 2025, 19:01
Sep 6, 2025, 18:05